The first cancer centers to use the new system were the Champalimaud Foundation in Lisbon, Portugal and Henry Ford Health System in Detroit, Michigan.
Die ersten Krebszentren, die das neue System einsetzten, waren die Champalimaud Foundation in Lissabon, Portugal und Henry Ford Health System in Detroit, Michigan.